Javier Torres-Jiménez

459 total citations
21 papers, 252 citations indexed

About

Javier Torres-Jiménez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Javier Torres-Jiménez has authored 21 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Javier Torres-Jiménez's work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Javier Torres-Jiménez is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Javier Torres-Jiménez collaborates with scholars based in Spain, United States and Italy. Javier Torres-Jiménez's co-authors include Alfredo Carrato, Isidre Vilacosta, Marı́a Jesús Rollán, Cristina Sarriá, J. Alberto San Román, Juan Antonio Castillo, María San Román, Javier Pozas, Teresa Alonso‐Gordoa and Javier Molina‐Cerrillo and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and International Journal of Molecular Sciences.

In The Last Decade

Javier Torres-Jiménez

15 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Torres-Jiménez Spain 8 80 76 68 60 60 21 252
Maria Gemma Pignataro Italy 8 100 1.3× 37 0.5× 33 0.5× 107 1.8× 22 0.4× 20 281
Dawn Swan Ireland 11 85 1.1× 43 0.6× 49 0.7× 79 1.3× 58 1.0× 43 377
Friederike Cordes Germany 10 39 0.5× 61 0.8× 81 1.2× 79 1.3× 32 0.5× 19 330
Katjana Schwab Germany 12 142 1.8× 32 0.4× 32 0.5× 74 1.2× 28 0.5× 23 285
Kikkie Poels Netherlands 9 157 2.0× 30 0.4× 26 0.4× 62 1.0× 98 1.6× 11 331
Naoki Watanabe Japan 11 109 1.4× 35 0.5× 43 0.6× 61 1.0× 16 0.3× 36 318
Benjamin Rivière France 9 73 0.9× 112 1.5× 104 1.5× 51 0.8× 8 0.1× 24 305
Ray Wilkinson Australia 15 62 0.8× 40 0.5× 36 0.5× 171 2.9× 12 0.2× 20 498
Yutaka Ozeki Japan 9 61 0.8× 66 0.9× 154 2.3× 43 0.7× 16 0.3× 69 335
Melanie Langheinrich Germany 12 150 1.9× 58 0.8× 149 2.2× 96 1.6× 11 0.2× 34 392

Countries citing papers authored by Javier Torres-Jiménez

Since Specialization
Citations

This map shows the geographic impact of Javier Torres-Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Torres-Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Torres-Jiménez more than expected).

Fields of papers citing papers by Javier Torres-Jiménez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Torres-Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Torres-Jiménez. The network helps show where Javier Torres-Jiménez may publish in the future.

Co-authorship network of co-authors of Javier Torres-Jiménez

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Torres-Jiménez. A scholar is included among the top collaborators of Javier Torres-Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Torres-Jiménez. Javier Torres-Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mezquita, Laura, Oliver Higuera, Sebastián Menao, et al.. (2025). Germline Mutation Analysis and Real-World Impact in a Selected Cohort of Patients with Non-Small Cell Lung Cancer: INHERITY LC Study. Clinical Lung Cancer.
2.
Torres-Jiménez, Javier, Mariano Ponz‐Sarvisé, Bruno Bockorny, et al.. (2025). First-in-human phase 1 dose escalation trial of OMTX705, a novel anti-fibroblast activation protein (FAP) antibody drug conjugate (ADC), in monotherapy and in combination with pembrolizumab in patients with solid tumors.. Journal of Clinical Oncology. 43(16_suppl). 3028–3028. 2 indexed citations
4.
Torres-Jiménez, Javier, et al.. (2024). Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments. Drugs. 84(5). 527–548. 7 indexed citations
5.
Baena, Javier, et al.. (2023). Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer. Cancers. 15(23). 5505–5505. 5 indexed citations
6.
7.
Torres-Jiménez, Javier, et al.. (2023). Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer. Cancers. 15(3). 566–566. 18 indexed citations
8.
Baena, Javier, et al.. (2023). EP14.02-07 Atypical Response to Metronomic Chemotherapy in a Patient with Advanced Thymoma. Journal of Thoracic Oncology. 18(11). S719–S720.
9.
Torres-Jiménez, Javier, et al.. (2022). Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene. Cancers. 14(15). 3718–3718. 8 indexed citations
10.
Fernández‐Guarino, M., et al.. (2022). Pure Bullous Pyoderma Gangrenosum, a Challenging Clinico-Pathological Diagnosis. Indian Journal of Dermatology. 67(4). 409–414. 1 indexed citations
11.
Torres-Jiménez, Javier, et al.. (2022). Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy. Diagnostics. 12(9). 2091–2091. 10 indexed citations
12.
Torres-Jiménez, Javier, et al.. (2021). Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital. Clinical & Translational Oncology. 23(7). 1474–1480. 9 indexed citations
13.
Torres-Jiménez, Javier, Víctor Albarrán, Javier Pozas, et al.. (2021). Novel Tyrosine Kinase Targets in Urothelial Carcinoma. International Journal of Molecular Sciences. 22(2). 747–747. 6 indexed citations
14.
Torres-Jiménez, Javier, et al.. (2021). 6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway. Journal of Thoracic Oncology. 16(4). S701–S701.
15.
Torres-Jiménez, Javier, et al.. (2021). Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist. Cancers. 13(23). 5938–5938. 11 indexed citations
16.
Castillo, J.J. Soto, Javier Pozas, María San Román, et al.. (2020). Tyrosine Kinase Receptors in Oncology. International Journal of Molecular Sciences. 21(22). 8529–8529. 73 indexed citations
17.
Torres-Jiménez, Javier, et al.. (2019). Survey of treatment recommendations for elderly patients with glioblastoma. Clinical & Translational Oncology. 22(8). 1329–1334. 4 indexed citations
18.
19.
Galarreta, José Ignacio Ruíz de, et al.. (2011). Features of recurrence of triple-negative (TN), non-metastatic breast cancer (NMBC) patients: A single institution study.. Journal of Clinical Oncology. 29(27_suppl). 180–180. 2 indexed citations
20.
Vilacosta, Isidre, Cristina Sarriá, J. Alberto San Román, et al.. (1994). Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers.. Circulation. 89(6). 2684–2687. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026